[Image courtesy of Phillips-Medisize]
Phillips-Medisize, a Molex company, announced today that it expanded its product portfolio with a new disposable pen injector.Hudson, Wisconsin-based Phillips-Medisize designed the new injector for high-volume manufacturing. It intends to offer pharmaceutical companies a familiar, competitive pen injector for faster, more efficient and cost-effective market entry.
Get the full story at our sister site, Drug Delivery Business News.
Hudson, Wisconsin-based Phillips-Medisize designed the new injector for high-volume manufacturing. It intends to offer pharmaceutical companies a familiar, competitive pen injector for faster, more efficient and cost-effective market entry.
The company plans to display the pen at Pharmapack Europe, according to a news release.
“A pen injector is an important addition to Phillips-Medisize’s expanding product and platform portfolio that empowers biopharma companies to accelerate the rollout of novel and generic drug treatments at significant economies of scale,” said Paul Chaffin, SVP and president of medical and pharmaceutical solutions, Molex. “This ‘ready to go’ solution offers all of the advantages expected from ‘state of the art’ pen designs while be…
A survey conducted by Molex and its Phillips-Medisize medical device delivery division highlights the importance of digitized drug delivery.
Lisle, Ill.-based Molex and Phillips-Medisize commissioned Dimensional Research to poll 215 qualified pharmaceutical professionals who are all stakeholders in a range of digital drug delivery devices, according to a news release.
Get the full story at our sister site, Drug Delivery Business News.
Paul Chaffin, SVP of Molex’s Medical and Pharmaceutical Solutions division
Paul Chaffin — most recently SVP of enterprise initiatives at Ecolab — has become SVP in charge of Molex’s Medical and Pharmaceutical Solutions division, including contract manufacturing giant Phillips-Medisize.
Chaffin will report to Molex CEO Joe Nelligan and will be a member of the company’s Global Leadership Team.
“Paul’s depth of healthcare, commercial and international experience combined with his strong leadership skills will be a big asset to not only our medical business but to the Molex leadership team. We’re confident that Paul will help fulfill our vision of expanding our global footprint with innovative and digitally connected medical solutions at a time when delivering top-quality care to patients around the world is so critical,” said Joe Nelligan, CEO of Molex.
Chaffin described the combined…